Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.South Korea |
First Approval Date09 May 1995 |
100 Clinical Results associated with Sannova Co., Ltd. /Pharmaceutical Business/
0 Patents (Medical) associated with Sannova Co., Ltd. /Pharmaceutical Business/
100 Deals associated with Sannova Co., Ltd. /Pharmaceutical Business/
100 Translational Medicine associated with Sannova Co., Ltd. /Pharmaceutical Business/